We are live on
!
Find out more
GBA
Garrison Bradford & Associates Portfolio holdings
AUM
$92.2M
1-Year Est. Return
19.08%
This Fund
S&P 500
This Quarter
Est. Return
+3.91%
1 Year Est. Return
+19.08%
3 Year Est. Return
+63.45%
5 Year Est. Return
+93.47%
10 Year Est. Return
+398.58%
AUM
$107M
AUM Growth
+$3.64M
(+3.5%)
Cap. Flow
+$210K
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
44.23%
Holding
118
New
7
Increased
10
Reduced
27
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$5.48M |
| 2 |
NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
|
+$798K |
| 3 |
Brookfield Renewable
BEP
|
+$438K |
| 4 |
TJX Companies
TJX
|
+$331K |
| 5 |
GM
GEN MOTORS CORP
GM
|
+$291K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$3.4M |
| 2 |
UnitedHealth
UNH
|
+$923K |
| 3 |
Gentherm
THRM
|
+$653K |
| 4 |
HIMX
Himax Technologies
HIMX
|
+$523K |
| 5 |
SAFE
Safehold
SAFE
|
+$435K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.08% |
| 2 | Energy | 15.82% |
| 3 | Industrials | 8.56% |
| 4 | Materials | 6.22% |
| 5 | Consumer Staples | 6.03% |
Similar funds
AW
JBL
YC
MA
ITG
ACMC
KAM
KA
Garrison Bradford & Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Garrison Bradford & Associates held 118 positions worth $107M, up 3.5% from $104M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Garrison Bradford & Associates's Q2 2014 filing shows 7 new, 10 increased, 27 reduced and 7 closed positions. Its largest new stake was BASF AKTIENGESELLT ADS(RP1 ORD: 47,050 shares worth $5.48M. The largest sale was Ionis Pharmaceuticals, an estimated $3.4M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 28% a quarter earlier, followed by Energy and Industrials.
- Garrison Bradford & Associates's largest Q2 2014 buy was BASF AKTIENGESELLT ADS(RP1 ORD: 47,050 shares worth $5.48M.
- Garrison Bradford & Associates added most to TJX Companies in Q2 2014, an estimated $331K increase.
- Garrison Bradford & Associates's biggest Q2 2014 reduction was UnitedHealth, cutting an estimated $923K.
- Garrison Bradford & Associates fully exited Ionis Pharmaceuticals in Q2 2014, selling an estimated $3.4M.
- Garrison Bradford & Associates's ten largest holdings make up 44% of its $107M portfolio in Q2 2014.
- Garrison Bradford & Associates opened 7 new positions and closed 7 in Q2 2014.
- Garrison Bradford & Associates's portfolio value rose 3.5% quarter-over-quarter to $107M.
Based on Garrison Bradford & Associates's 13F filing for Q2 2014, filed 14 Jul 2014.